These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


441 related items for PubMed ID: 8405707

  • 1. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W, Seissler J, Northemann W, Wolfahrt S, Meinck HM, Scherbaum WA.
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [Abstract] [Full Text] [Related]

  • 2. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
    Chaillous L, Delamaire M, Martignat L, Maugendre D, Marre M, Mathieu E, Limal JM, Charbonnel B, Allannic H, Saï P.
    Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF.
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [Abstract] [Full Text] [Related]

  • 4. Islet cell antibodies: variable immunostaining of pancreatic islet cells and carcinoid tissue.
    Hallberg A, Juhlin C, Berne C, Kämpe O, Karlsson FA.
    J Intern Med; 1995 Sep; 238(3):207-13. PubMed ID: 7673849
    [Abstract] [Full Text] [Related]

  • 5. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
    Björk E, Velloso LA, Kämpe O, Karlsson FA.
    Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
    [Abstract] [Full Text] [Related]

  • 6. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA, Rabin DU, Rowley MJ.
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [Abstract] [Full Text] [Related]

  • 7. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
    Ziegler B, Schlosser M, Lühder F, Strebelow M, Augstein P, Northemann W, Powers AC, Ziegler M.
    Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
    [Abstract] [Full Text] [Related]

  • 8. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Böhm BO, Richter W.
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical differentiation of monoclonal GAD antibodies recognizing linear or conformational epitope regions.
    Augstein P, Ziegler B, Schlosser M, Flassig S, Strebelow M, Ziegler M.
    Pancreas; 1997 Aug; 15(2):139-46. PubMed ID: 9260198
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.
    Richter W, Endl J, Eiermann TH, Brandt M, Kientsch-Engel R, Thivolet C, Jungfer H, Scherbaum WA.
    Proc Natl Acad Sci U S A; 1992 Sep 15; 89(18):8467-71. PubMed ID: 1382289
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C, Radford PM, Al-Bukhari TA, Lai M, Bottazzo GF, Todd I.
    Clin Exp Immunol; 1998 Mar 15; 111(3):497-505. PubMed ID: 9528889
    [Abstract] [Full Text] [Related]

  • 14. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM.
    Chaillous L, Delamaire M, Elmansour A, Maugendre D, Rohmer V, Joseph MG, Lecomte P, Limal JM, Charbonnel B, Allannic H.
    Diabetologia; 1994 May 15; 37(5):491-9. PubMed ID: 8056187
    [Abstract] [Full Text] [Related]

  • 15. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
    Morgenthaler NG, Seissler J, Achenbach P, Glawe D, Payton M, Meinck HM, Christie MR, Scherbaum WA.
    Autoimmunity; 1997 May 15; 25(4):203-11. PubMed ID: 9344328
    [Abstract] [Full Text] [Related]

  • 16. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
    Walikonis JE, Lennon VA.
    Mayo Clin Proc; 1998 Dec 15; 73(12):1161-6. PubMed ID: 9868413
    [Abstract] [Full Text] [Related]

  • 17. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M, Karjalainen J, Akerblom HK.
    Diabetes Care; 1998 Oct 15; 21(10):1670-3. PubMed ID: 9773728
    [Abstract] [Full Text] [Related]

  • 18. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.
    Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK.
    J Clin Invest; 1993 Jan 15; 91(1):350-6. PubMed ID: 8423231
    [Abstract] [Full Text] [Related]

  • 19. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ, Honeyman MC, Harrison LC.
    J Autoimmun; 1992 Dec 15; 5(6):759-70. PubMed ID: 1489487
    [Abstract] [Full Text] [Related]

  • 20. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.
    De Aizpurua HJ, Wilson YM, Harrison LC.
    Proc Natl Acad Sci U S A; 1992 Oct 15; 89(20):9841-5. PubMed ID: 1409709
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.